Sanofi (FRA:SNW)
Germany
· Delayed Price · Currency is EUR 82.98
-0.19 (-0.23%)
Last updated: Aug 14, 2025
Sanofi Revenue
Sanofi had revenue of 10.74B EUR in the quarter ending June 30, 2025. This brings the company's revenue in the last twelve months to 45.74B, up 15.65% year-over-year. In the year 2024, Sanofi had annual revenue of 44.29B with 7.73% growth.
Revenue (ttm)
45.74B
Revenue Growth
+15.65%
P/S Ratio
2.22
Revenue / Employee
551.87K
Employees
82,878
Market Cap
101.44B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 44.29B | 3.18B | 7.73% |
| Dec 31, 2023 | 41.11B | 805.00M | 2.00% |
| Dec 31, 2022 | 40.30B | 1.13B | 2.88% |
| Dec 31, 2021 | 39.18B | 1.81B | 4.83% |
| Dec 31, 2020 | 37.37B | -262.00M | -0.70% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| SAP SE | 35.89B |
| Siemens Aktiengesellschaft | 78.30B |
| Deutsche Telekom AG | 120.55B |
| Allianz SE | 109.02B |
| Siemens Energy AG | 38.39B |
| Rheinmetall AG | 10.67B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 62.33B |
| Deutsche Bank Aktiengesellschaft | 30.07B |
Sanofi News
- 1 day ago - UK Government, Eli Lilly Partner To Target Obesity Health Gaps - Benzinga
- 2 days ago - Sanofi reportedly halts sales of cholesterol drug Praluent in China amid limited availability - Seeking Alpha
- 2 days ago - Sanofi stops supply of high cholesterol drug to China due to limited availability - Reuters
- 7 days ago - Sanofi: Playing To Win - Seeking Alpha
- 7 days ago - Emcure Pharmaceuticals Reports Strong Q1 FY26 Results with 16% Revenue Growth and 41% Jump in Profit - Business Upturn
- 7 days ago - Novavax raises 2025 revenue target to $1.05B with milestone payments and streamlined expenses as Sanofi partnership progresses - Seeking Alpha
- 8 days ago - Press Release: Sanofi completes the acquisition of Vigil Neuroscience, Inc. - GlobeNewsWire
- 9 days ago - What's Driving the Market Sentiment Around Sanofi? - Benzinga